HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kinji Ishikawa Selected Research

Secondary Prevention

11/2005Calcium antagonists for secondary prevention of myocardial infarction: is there a need to shift from short-acting to long-acting types?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kinji Ishikawa Research Topics

Disease

8Myocardial Infarction
11/2005 - 07/2002
4Cardiovascular Diseases (Cardiovascular Disease)
11/2005 - 07/2002
4Ischemia
07/2003 - 03/2002
3Heart Failure
11/2003 - 06/2002
2Hyperventilation
04/2007 - 06/2002
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2003 - 03/2002
1Stroke (Strokes)
02/2006
1Atrial Fibrillation
02/2006
1Hemorrhage
02/2006
1Iatrogenic Disease
12/2005
1Arteriovenous Fistula
06/2004
1False Aneurysm (Pseudoaneurysm)
06/2004
1Cardiac Sudden Death (Sudden Cardiac Arrest)
11/2003
1Cardiomyopathies (Cardiomyopathy)
08/2003
1Hyperplasia
06/2002
1Spasm (Spasms)
06/2002
1Vascular System Injuries
06/2002

Drug/Important Bio-Agent (IBA)

4Nitric Oxide Synthase (NO Synthase)IBA
07/2003 - 03/2002
4NG-Nitroarginine Methyl Ester (L-NAME)IBA
07/2003 - 03/2002
4Adenosine Triphosphate (ATP)IBA
07/2003 - 03/2002
2Acetylcholine (Acetylcholine Chloride)FDA Link
04/2007 - 06/2002
2CholesterolIBA
12/2005 - 11/2003
2NitratesIBA
08/2004 - 07/2002
2Pravastatin (Pravachol)FDA LinkGeneric
11/2003 - 03/2002
2Metformin (Glucophage)FDA LinkGeneric
07/2003 - 01/2003
2Phosphorus (Red Phosphorus)IBA
03/2002 - 03/2002
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2006
1AnticoagulantsIBA
02/2006
1Amlodipine (Norvasc)FDA LinkGeneric
11/2005
1CalciumIBA
11/2005
1Nifedipine (Adalat)FDA LinkGeneric
11/2005
1Fibrinolytic Agents (Antithrombotic Agents)IBA
09/2004
1Pharmaceutical PreparationsIBA
01/2004
12,4-thiazolidinedione (thiazolidinedione)IBA
07/2003
1Hypoglycemic Agents (Hypoglycemics)IBA
07/2003
1BiguanidesIBA
07/2003
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2003
1Pioglitazone (Actos)FDA Link
07/2003
1Thallium-201IBA
07/2002
1Tissue Plasminogen Activator (Alteplase)FDA Link
06/2002
1Heparin (Liquaemin)FDA LinkGeneric
06/2002
1Iodine-123IBA
06/2002
1DiureticsIBA
06/2002
13-Iodobenzylguanidine (Iobenguane)IBA
06/2002
1Phosphates (Orthophosphate)IBA
03/2002
1candesartanIBA
03/2002
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2002
1temocaprilatIBA
03/2002
1Cardiotonic Agents (Cardiac Stimulants)IBA
03/2002
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
03/2002
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
03/2002
1Coenzyme A (CoA)IBA
03/2002
1K201 compoundIBA
03/2002
1Angiotensin IIIBA
03/2002

Therapy/Procedure

2Therapeutics
02/2006 - 08/2003
1Secondary Prevention
11/2005
1Percutaneous Coronary Intervention
10/2004
1Thrombolytic Therapy
09/2004
1Punctures
06/2004
1Vascular Surgical Procedures
06/2004
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
08/2003
1Transdermal Patch
07/2002